Status:

COMPLETED

Double-blind Randomized Controlled Trial in Severe Alcoholic Hepatitis

Lead Sponsor:

University Hospital, Lille

Collaborating Sponsors:

Ministry of Health, France

Conditions:

Alcoholic Hepatitis

Alcoholic Liver Disease

Eligibility:

All Genders

18-70 years

Phase:

PHASE3

Brief Summary

The treatment of severe forms of alcoholic hepatitis (AH) constitutes a major challenge for clinicians involved in the management of severe alcoholic liver disease. In patients with Maddrey function h...

Detailed Description

The aim of the present study is to determine whether or not the adjunction of Pentoxifylline to corticosteroids would improve 6-month survival of patients with severe alcoholic hepatitis. This multice...

Eligibility Criteria

Inclusion

  • Alcohol consumption more than 40 gram/day for women and 50 gram/day for men
  • Maddrey discriminant function higher than 32
  • Onset of jaundice within the 3 previous months
  • Biopsy-proven alcoholic hepatitis

Exclusion

  • Hypersensitivity to pentoxifylline
  • Any severe disease that may potential affect survival such as cardiac failure, ischemic cardiopathy, respiratory failure
  • Any neoplasm that occurred within the 2 previous years
  • Hepatocellular carcinoma or any previous diagnosis of hepatocellular carcinoma
  • Portal thrombosis
  • Severe gastrointestinal bleeding
  • Uncontrolled sepsis within the 7 previous days
  • Hepatorenal syndrome type I
  • Viral and fungal infection
  • Acute pancreatitis
  • Any tuberculosis that occurred within the 5 previous years
  • Psychiatric disorders that contraindicate the use of corticosteroids
  • Infection related to virus of the hepatites B or C
  • HIV infection (Human immunodeficiency virus)
  • Any treatment with corticosteroids, immunosuppressive agents, budesonide, thalidomide or pentoxifylline that was given within the previous year
  • Pregnancy or breast feeding

Key Trial Info

Start Date :

December 1 2007

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

January 1 2011

Estimated Enrollment :

278 Patients enrolled

Trial Details

Trial ID

NCT01214226

Start Date

December 1 2007

End Date

January 1 2011

Last Update

June 1 2011

Active Locations (28)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 7 (28 locations)

1

University hospital

Brussels, Belgium, 1070

2

University hospital

Angers, France, 49933

3

Centre hospitalier

Béthune, France, 62408

4

Hôpital Jean Verdier (AH-HP)

Bondy, France, 93143